background image

Paid Clinical Trials Orlando

Discover 974 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Orlando FL, Tampa FL, Jacksonville FL, Doral FLshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Orange City FL, Jacksonville FL, Indianapolis IN, Houston TXshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Orlando FL, Bay Pines FL, Miami FL, Charleston SCshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Ocoee FL, Inverness FL, Ocala FL, Jacksonville FLshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

Orlando FL, Birmingham AL, Huntersville NC, Fairfax VAshow 11 more

Code:

NCT06265727

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-701

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

Recruiting
PHASE3

Sponsor:

Vaccinogen Inc

Location:

Port Orange FL

Code:

NCT02448173

Conditions

Stage II Colon Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OncoVAX and Surgery

Surgery

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Orlando FL, Hollywood FL, Miami FL, Chapel Hill NCshow 10 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Orlando FL, DeBary FL, Daytona Beach FL, Ormond Beach FLshow 76 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Recruiting
PHASE3

Sponsor:

Cerevance

Location:

Orlando FL, Maitland FL, Port Orange FL, Ocala FLshow 20 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Recruiting
PHASE2
PHASE3

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Location:

Orlando FL, Tampa FL, Jacksonville FL, Atlanta GAshow 25 more

Code:

NCT05729373

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SEP-363856

Placebo

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Orlando FL, Altamonte Springs FL, Thomasville GA, Baton Rouge LAshow 20 more

Code:

NCT06312176

Conditions

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Paclitaxel

Nab-paclitaxel

Capecitabine

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando